MILES CONSUMER HEALTHCARE NAMES TORBEN CHRISTENSEN PRESIDENT,
This article was originally published in The Tan Sheet
MILES CONSUMER HEALTHCARE NAMES TORBEN CHRISTENSEN PRESIDENT, the firm announced March 1. Formerly VP and general manager of Miles dental products business, Christensen succeeds Werner Spinner as consumer healthcare president. Spinner "is returning to Germany to assume a senior executive position with Miles' parent company," Bayer AG, Miles said. Christensen will report to Pharmaceutical Division President Horst Wallrabe. Christensen, 50, has been in a "transition period" toward the new title since October 1992, when he effectively left the dental division for consumer healthcare, Miles said. Miles consumer health brands include Alka-Seltzer, One-a-Day, Mycelex-7, Bactine and Flintstones vitamins. Replacing Christensen atop the dental products division is Bob Foyle, 44, previously dental division director of sales and marketing. Christensen has worked at Miles for 26 years. A graduate of the University of Copenhagen, he began his career in 1966 as a sales representative for the Denmark branch of the former Ames division of Bayer. In 1976, Christensen transferred to Miles in Elkhart, Ind. as manager of marketing development for Miles diagnostic division's urine chemistry business. Christensen moved up to VP-international marketing for the diagnostics division and became VP-U.S. marketing and sales of that division in 1987. In April 1990, he was named head of the dental division. Spinner headed Miles consumer healthcare effort for nearly three years, assuming the post in June 1990. Last year Miles U.S. consumer health business posted sales of almost $ 275 mil., the firm said.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC